What is it about?
new treatments for joint diseases
Featured Image
Why is it important?
helps explaining the advantages and disadvantages of biological therapy in ankylosing spondylitis
Read the Original
This page is a summary of: Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis, Therapeutics and Clinical Risk Management, November 2015, Dove Medical Press,
DOI: 10.2147/tcrm.s55928.
You can read the full text:
Contributors
The following have contributed to this page
